BEAM
Price
$26.26
Change
-$1.63 (-5.84%)
Updated
Feb 4, 01:32 PM (EDT)
Capitalization
2.83B
27 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$4.72
Change
-$0.28 (-5.60%)
Updated
Feb 3 closing price
Capitalization
1.3B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs TSHA

Header iconBEAM vs TSHA Comparison
Open Charts BEAM vs TSHABanner chart's image
Beam Therapeutics
Price$26.26
Change-$1.63 (-5.84%)
Volume$523
Capitalization2.83B
Taysha Gene Therapies
Price$4.72
Change-$0.28 (-5.60%)
Volume$1.37M
Capitalization1.3B
BEAM vs TSHA Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. TSHA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and TSHA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BEAM: $27.89 vs. TSHA: $4.72)
Brand notoriety: BEAM and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 66% vs. TSHA: 45%
Market capitalization -- BEAM: $2.83B vs. TSHA: $1.3B
BEAM [@Biotechnology] is valued at $2.83B. TSHA’s [@Biotechnology] market capitalization is $1.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -9.15% price change this week, while TSHA (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.83B) has a higher market cap than TSHA($1.3B). BEAM YTD gains are higher at: 0.613 vs. TSHA (-14.182). TSHA has higher annual earnings (EBITDA): -98.71M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. TSHA (297M). TSHA has less debt than BEAM: TSHA (69M) vs BEAM (151M). BEAM has higher revenues than TSHA: BEAM (55.7M) vs TSHA (6.31M).
BEAMTSHABEAM / TSHA
Capitalization2.83B1.3B218%
EBITDA-434.55M-98.71M440%
Gain YTD0.613-14.182-4%
P/E RatioN/A2.70-
Revenue55.7M6.31M883%
Total Cash1.08B297M362%
Total Debt151M69M219%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMTSHA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYYX13.820.07
+0.51%
American Century Global Real Estate Y
FDEKX74.14N/A
N/A
Fidelity Disciplined Equity K
GSACX22.98-0.03
-0.13%
Goldman Sachs China Equity C
TSFIX15.88-0.14
-0.87%
Touchstone Small Cap Institutional
HSWTX22.21-0.20
-0.89%
Hartford Schroders International Stk R5

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+1.29%
PCVX - TSHA
53%
Loosely correlated
-2.91%
NGNE - TSHA
50%
Loosely correlated
-4.20%
RGNX - TSHA
47%
Loosely correlated
+0.74%
BEAM - TSHA
44%
Loosely correlated
-0.11%
MGTX - TSHA
42%
Loosely correlated
+2.68%
More